Keeping tabs on this stock: Seneca Biopharma, Inc. (SNCA) rushed in the after-market trading
Seneca Biopharma, Inc. (Nasdaq: SNCA), shares soared 11.5% to $0.89 in the AH trading session as the biopharmaceutical corporation devoted to producing new therapies for conditions of high medical need, recently published its financial results for the quarter ended 30 September 2020. On September 30, 2020, cash was approximately $12.7 million compared to approximately $15.8 […]
